Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

For Cancer Patients, Sugar-Coated Cells are Deadly

Published: Friday, June 27, 2014
Last Updated: Friday, June 27, 2014
Bookmark and Share
Paszek’s lab will focus on developing high-resolution microscopy to further study cell membrane-related cancer mechanisms.

Every living cell’s surface has a protein-embedded membrane that’s covered in polysaccharide chains - a literal sugar coating. On cancer cells, this coating is especially thick and pronounced.

A Cornell researcher has found that a cancer cell’s sugary outside is anything but sweet. The thick, slimy coating that would feel like a slug’s skin is a crucial determinant of the cell’s survival, it turns out. Consisting of long, sugar-decorated molecules called glycoproteins, the coating causes physical changes in the cell membrane that make the cell better able to thrive - leading to a more lethal cancer.

Matthew Paszek, assistant professor of chemical and biomolecular engineering, led the study on glycoprotein-induced cancer cell survival, published online in Nature June 25. Before he joined the Cornell faculty in January, Paszek was a postdoctoral fellow at the Kavli Institute at Cornell for Nanoscale Science.

The Nature study was initiated by Paszek and co-author Valerie Weaver at the University of California, San Francisco, and includes other collaborators in bioinformatics, clinical research and chemistry. At Cornell, Paszek’s lab will focus on developing high-resolution microscopy to further study cell membrane-related cancer mechanisms.

The researchers found that long glycoprotein chains on a cancer cell’s surface cause the cell membrane to push away from its environment and bend inward. This physical change causes adhesion receptors on the cell surface called integrins to clump together. Integrins bind to protein scaffolds in their environment and regulate pretty much everything a cell does - movement, change and growth.

This clustering mechanism causes the integrins to alter the cell’s normal signaling, leading to unchecked growth and survival.

The mechanics of this sugar coating and its subsequent chemical signaling is likely dictated by basic factors like nutrient availability and metabolism - things with implications for diet and genetic makeup, for example, Paszek said. “Changes to the sugar composition on the cell surface could alter physically how receptors are organized,” he said. “That’s really the big thing: coupling the regulation of the sugar coating to these biochemical signaling molecules.”

The paper, “The cancer glycocalyx mechanically primes integrin-mediated growth and survival,” was the subject of a “News and Views” feature in Nature. Paszek’s work was supported by the Kavli Institute at Cornell for Nanoscale Science.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Tumor-suppressing Gene Lends Insight to Cancer Treatment
Researchers have found that delicate replication process derails if a gene named PTEN has mutated or is absent.
Tuesday, July 14, 2015
Computer Model Reveals Cancer's Energy Source
Findings focused on the energy-making process in cancer cells known as the Warburg Effect.
Tuesday, August 19, 2014
Gold-Plated Nano-Bits Find, Destroy Cancer Cells
Scientists have merged tiny gold and iron oxide particles, then added antibody guides to steer them through the bloodstream toward colorectal cancer cells.
Monday, October 21, 2013
Genetic Switches Play Big Role in Human Evolution
Study offers further proof that the divergence of humans from chimpanzees was profoundly influenced by mutations to DNA sequences.
Wednesday, June 12, 2013
Turn out the Light: 'Switch' Determines Cancer Cell Fate
Like picking a career or a movie, cells have to make decisions – and cancer results from cells making wrong decisions.
Friday, May 03, 2013
Nano Compartments May Aid Drug Delivery, Catalyst Design
Spongelike nanoparticles whose pores can be filled with drugs offer the promise of drug delivery to specific targets in the body, avoiding unpleasant side effects.
Monday, April 22, 2013
Scientists Develop World's Smallest Drug Deliverer
Cornell researchers have created a pore in “Cornell Dots” – brightly glowing nanoparticles nicknamed C-Dots – that can carry medicine.
Friday, April 12, 2013
DNA Editor Named Runner-up Breakthrough of 2012
A discovery that allows life scientists to precisely edit genomes for everything from crop and livestock improvement to human gene and cell therapy was named runner-up for Science magazine's 2012 Breakthrough of the Year.
Wednesday, February 27, 2013
Organic Metamaterial Flows like a Liquid, Remembers its Shape
A bit reminiscent of the Terminator T-1000, a new material created by Cornell researchers is so soft that it can flow like a liquid and then, strangely, return to its original shape.
Tuesday, December 04, 2012
Study: How Cells form 'Trash Bags' for Recycling Waste
A class of membrane-sculpting proteins create vesicles that carry old and damaged proteins from the surface of cellular compartments into internal recycling plants where the waste is degraded and components are reused.
Tuesday, October 23, 2012
Metastatic 'Switch' Sheds New Light on Colon Cancer
What kills cancer patients often isn't the primary tumor; it's when the tumor metastasizes - or spreads the cancer to other areas of the body.
Tuesday, September 11, 2012
The Force is with us: GEDI Chip Sorts Prostate Cancer Cells
Geometrically Enhanced Differential Immunocapture chip identify and collect cancer cells from a patient's bloodstream.
Friday, June 29, 2012
Some Stem Cells Can Trigger Tumors
When in contact with even trace amounts of cancer cells, stem cells can create a microenvironment suitable for more tumors to grow.
Wednesday, June 06, 2012
Scientific News
Detection of HPV in First-Void Urine
Similar sensitivity of HPV test on first void urine sample compared to cervical smear.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
First Gene Therapy Successful Against Human Aging
American woman gets biologically younger after gene therapies.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!